Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

Indian pharma companies are challenging Novo Nordisk's semaglutide patents in court, which could pave the way for cheaper ...

We live in a world where $1 billion of prescription medications are left at the pharmacy counter each year, often because ...

Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site will, too.

With millions of Americans prescribed GLP-1 drugs, researchers warn of catastrophic risks ignored by Big Pharma.

Representative Marjorie Taylor Greene is back in the spotlight for her stock trades, this time taking a stake in the ...

Prescription savings platform GoodRx is collaborating with pharma giant Novo Nordisk to make Ozempic and Wegovy pens ...

Jameela Jamil issued multiple clarifications after posting about Serena Williams' recent endorsement of weight loss ...

Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses.

GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. About 14.9 million U.S.